Jamjoom Pharma to disclose Q1 2025 results on April 30

20/04/2025 Argaam
Logo ofJamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma)

Logo of Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma)

TASI-listed Jamjoom Pharmaceuticals Factory Co.’s (Jamjoom Pharma) will announce its Q1 2025 financial results before the start of trading on April 30, 2025, according to a statement to Tadawul.

 

The company will host its earnings call on the same day at 3:00 pm KSA time to discuss the financial results with investors and analysts.

 

For more news on listed companies

 

The presentation for the earnings call will be uploaded on the investor relations webpage on the company’s website, the statement added.

 

According to data compiled by Argaam, financial analysts’ average profit estimate for Jamjoom Pharma in Q1 2025 stood at SAR 128 million.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.